EP547

DRUG2 trials

Sponsors

Escient Pharmaceuticals, Inc

Conditions

CholestasisKidney FailurePruritus

Phase 1

Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

CompletedNCT04510090

Escient Pharmaceuticals, IncCholestasis, Kidney Failure, Pruritus

Start: 2020-09-07End: 2021-07-08Updated: 2025-08-08

Phase 2

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

CompletedNCT05525520

Escient Pharmaceuticals, IncPruritus

Start: 2022-10-06End: 2024-09-05Updated: 2025-07-31